RacGAP1 Promotes the Malignant Progression of Cervical Cancer by Regulating AP-1 Via MiR-192 and P-JNK

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2022 Jul 13

PMID 35831303

Authors

Tianli Zhang

Chunyan Wang

Kun Wang

Ying Liang

Ting Liu

Liping Feng

Xingsheng Yang

Affiliations

Soon will be listed here.

Abstract

Cervical cancer (CC) is the most frequently diagnosed genital tract cancer in females worldwide. Rac GTPase-activating protein 1 (RacGAP1) is one of the specific GTPase-activating proteins. As a novel tumor protooncogene, overexpression of RacGAP1 was related to the occurrence of various tumors, but its function in CC is still unclear. In this study, bioinformatics analyses showed that RacGAP1 might be a key candidate gene in the progression of CC. RacGAP1 was significantly overexpressed in CC tissues. High RacGAP1 expression was positively associated with poor prognosis. Downregulating RacGAP1 significantly inhibited the proliferation, migration, and invasion of CC cells, while overexpressing RacGAP1 had the opposite effects. Further research showed that miR-192, which plays as a tumor suppressor in CC, was identified as a downstream target of RacGAP1 in CC cells. miR-192 inhibition could partially rescue the decrease in cell proliferation, migration, and invasion caused by RacGAP1 downregulation. In opposite, miR-192 overexpression could decrease the promotion of malignant progression caused by RacGAP1 upregulation. Mechanism studies revealed that RacGAP1 could regulate the expression and phosphorylation of c-Jun, which was the component of AP-1, via miR-192 and p-JNK separately. These findings suggested that RacGAP1 promoted tumorigenicity, migration, and invasion of CC. Therefore, it represented a potential novel prognostic marker in CC and may probably be a therapeutic target.

Citing Articles

Molecular mechanisms of miR-192 in cancer: a biomarker and therapeutic target.

Yang Y, Razak S, Ismail I, Ma Y, Yunus M Cancer Cell Int. 2025; 25(1):94.

PMID: 40087755 DOI: 10.1186/s12935-025-03666-5.

The Expression Regulation and Cancer-Promoting Roles of RACGAP1.

Lin J, Zhu Y, Lin Z, Yu J, Lin X, Lai W Biomolecules. 2025; 15(1).

PMID: 39858398 PMC: 11760467. DOI: 10.3390/biom15010003.

Targeting RACGAP1 suppresses growth hormone pituitary adenoma growth.

Sun F, Ji C, Zhou X, Zhang Y, Cheng H, Ye Z Endocrine. 2024; .

PMID: 39607642 DOI: 10.1007/s12020-024-04116-4.

Elevated RACGAP1 Expression Enhances Malignant Potential in Lung Adenocarcinoma and Serves as a Prognostic Factor.

Lai W, Su Y, Li Y, Zuo Y, He K, Zhang T J Cancer. 2024; 15(13):4244-4258.

PMID: 38947404 PMC: 11212091. DOI: 10.7150/jca.96334.

Reciprocal regulation between RACGAP1 and AR contributes to endocrine therapy resistance in prostate cancer.

Wang J, Liu H, Yu Z, Zhou Q, Sun F, Han J Cell Commun Signal. 2024; 22(1):339.

PMID: 38898473 PMC: 11186203. DOI: 10.1186/s12964-024-01703-w.

References

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Sahin S, Gonul I, Cakir A, Seckin S, Uluoglu O . Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer. Int J Surg Pathol. 2016; 24(7):607-13. DOI: 10.1177/1066896916653211. View

Du X, Qi F, Lu S, Li Y, Han W . Nicotine upregulates FGFR3 and RB1 expression and promotes non-small cell lung cancer cell proliferation and epithelial-to-mesenchymal transition via downregulation of miR-99b and miR-192. Biomed Pharmacother. 2018; 101:656-662. DOI: 10.1016/j.biopha.2018.02.113. View

Breznau E, Semack A, Higashi T, Miller A . MgcRacGAP restricts active RhoA at the cytokinetic furrow and both RhoA and Rac1 at cell-cell junctions in epithelial cells. Mol Biol Cell. 2015; 26(13):2439-55. PMC: 4571299. DOI: 10.1091/mbc.E14-11-1553. View

Huang Q, Hou S, Zhu X, Liu S . MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway. World J Surg Oncol. 2020; 18(1):29. PMC: 6998165. DOI: 10.1186/s12957-020-1798-y. View

Kang D, Lee S, Hwang W, Lee B, Choi Y, Suh Y . Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells. Cancer Res. 2016; 77(1):142-152. DOI: 10.1158/0008-5472.CAN-15-3032. View

Wu M, Ke P, Horng J . RacGTPase-activating protein 1 interacts with hepatitis C virus polymerase NS5B to regulate viral replication. Biochem Biophys Res Commun. 2014; 454(1):19-24. DOI: 10.1016/j.bbrc.2014.10.008. View

Vartanian R, Masri J, Martin J, Cloninger C, Holmes B, Artinian N . AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation. Mol Cancer Res. 2010; 9(1):115-30. PMC: 3105464. DOI: 10.1158/1541-7786.MCR-10-0105. View

Chen T, Yang S, Xu J, Lu W, Xie X . Transcriptome sequencing profiles of cervical cancer tissues and SiHa cells. Funct Integr Genomics. 2019; 20(2):211-221. DOI: 10.1007/s10142-019-00706-y. View

10.

Nead M, Baglia L, Antinore M, Ludlow J, McCance D . Rb binds c-Jun and activates transcription. EMBO J. 1998; 17(8):2342-52. PMC: 1170577. DOI: 10.1093/emboj/17.8.2342. View

11.

Yeh C, Sung W, Lai H, Hsieh M, Yen H, Su T . Opposing prognostic roles of nuclear and cytoplasmic RACGAP1 expression in colorectal cancer patients. Hum Pathol. 2015; 47(1):45-51. DOI: 10.1016/j.humpath.2015.09.002. View

12.

Kim J, Kim S, Noh E, Song H, Lee G, Kwon K . Reversine inhibits MMP-1 and MMP-3 expressions by suppressing of ROS/MAPK/AP-1 activation in UV-stimulated human keratinocytes and dermal fibroblasts. Exp Dermatol. 2018; 27(3):298-301. DOI: 10.1111/exd.13494. View

13.

Yang X, Cao X, He P, Li J, Feng M, Zhang Y . Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Gastroenterology. 2018; 155(4):1233-1249.e22. DOI: 10.1053/j.gastro.2018.07.010. View

14.

Saigusa S, Tanaka K, Mohri Y, Ohi M, Shimura T, Kitajima T . Clinical significance of RacGAP1 expression at the invasive front of gastric cancer. Gastric Cancer. 2014; 18(1):84-92. DOI: 10.1007/s10120-014-0355-1. View

15.

Han Y, Zhao X, Sun Y, Sui Y, Liu J . Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway. J Cell Physiol. 2018; 234(4):3598-3612. DOI: 10.1002/jcp.27048. View

16.

Zhao Y, Tang X, Huang Y, Tang Q, Ma C, Zheng F . Interaction Of c-Jun And HOTAIR- Increased Expression Of p21 Converge In Polyphyllin I-Inhibited Growth Of Human Lung Cancer Cells. Onco Targets Ther. 2019; 12:10115-10127. PMC: 6883933. DOI: 10.2147/OTT.S226830. View

17.

Ye N, Ding Y, Wild C, Shen Q, Zhou J . Small molecule inhibitors targeting activator protein 1 (AP-1). J Med Chem. 2014; 57(16):6930-48. PMC: 4148154. DOI: 10.1021/jm5004733. View

18.

Nishitani J, Nishinaka T, Cheng C, Rong W, Yokoyama K, Chiu R . Recruitment of the retinoblastoma protein to c-Jun enhances transcription activity mediated through the AP-1 binding site. J Biol Chem. 1999; 274(9):5454-61. DOI: 10.1074/jbc.274.9.5454. View

19.

Kamijo K, Ohara N, Abe M, Uchimura T, Hosoya H, Lee J . Dissecting the role of Rho-mediated signaling in contractile ring formation. Mol Biol Cell. 2005; 17(1):43-55. PMC: 1345645. DOI: 10.1091/mbc.e05-06-0569. View

20.

Hartenstein B, Teurich S, Hess J, Schenkel J, Schorpp-Kistner M, Angel P . Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB. EMBO J. 2002; 21(23):6321-9. PMC: 136952. DOI: 10.1093/emboj/cdf648. View